論文・技術情報追加のお知らせ

①Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: A real-world study of the FDA adverse event reporting system.

免疫チェックポイント阻害剤に関連する後天性血栓性血小板減少性紫斑病調査研究

対象DB：FAERS

②Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting SystemFAERS.

抗真菌剤トリアゾール系薬剤に関連したトルサード・ド・ポアント、QT延長の調査研究

対象DB：FAERS

③A Real-World Disproportionality Analysis of Olaparib: Data Mining of the Public Version of FDA Adverse Event Reporting System.

オラパリブのファーマコビジランス研究

対象DB：FAERS

④Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data.

ポリADPリボースポリメラーゼ（PARP）阻害剤使用後の骨髄異形成症候群／急性骨髄性白血病調査研究

対象DB：FAERS,EudraVigilance

⑤Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system.

インフルエンザワクチンとCOVID-19ワクチンの製造販売後安全性プロファイルの比較研究

対象DB：VAERS

⑥Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database.

デュルバルマブによる肺毒性評価研究

対象DB：JADER

⑦Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.

COVID-19ワクチン接種後の有害事象としてのリウマチ性多発筋痛および多発筋痛様症候群

対象DB：VigiBase